Inactive Instrument

Alexza Pharmaceuticals, Inc. Share Price Nasdaq

Stocks

End-of-day quote Nasdaq
- ^USD	-

29/16/29	Alexza Pharmaceuticals : Reports Fourth Quarter and Year End 2015 Financial Results	PU
16/16/16	Alexza Pharmaceuticals : to Report 2015 Year End Financial Results and Provide Company Update on Monday, March 28, 2016	PU
10/16/10	Alexza Pharmaceuticals : Receives Positive Nasdaq Listing Determination	PU
27/16/27	Alexza Pharmaceuticals : Confirms Grupo Ferrer Non-binding Letter of Intent	PU
24/16/24	Alexza Pharmaceuticals : Reacquires U.S. Commercial Rights for ADASUVE® (loxapine) inhalation powder	PU

22/15/22	Alexza Pharmaceuticals : Les valeurs à suivre sur les marchés américains
22/15/22	USA-Les valeurs à suivre à Wall Street

Manager	Title	Age	Since
Mario Rovirosa Escosura CEO	Chief Executive Officer	-	-
Stacy Palermini DFI	Director of Finance/CFO	-	01/01/2003
Wolfgang Schmidt PRN	Corporate Officer/Principal	-	01/05/2019

Director	Title	Age	Since
Jorge Ramentol Massana BRD	Director/Board Member	-	21/06/2016
Joan Fanés Trillo BRD	Director/Board Member	-	21/06/2016
Sergio Ferrer-Salat Serra di Migni BRD	Director/Board Member	-	21/06/2016

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	-4.83%	+2.88%	+55.87%	+69.12%	6.94TCr
ARGENX SE	+0.02%	+1.07%	+10.63%	+76.66%	5.72TCr
LONZA GROUP AG	-1.34%	+2.98%	+24.79%	+100.18%	5.76TCr
IQVIA HOLDINGS INC.	+2.51%	+1.45%	+28.62%	+36.69%	4.37TCr
BEONE MEDICINES AG	+5.65%	+10.67%	+23.32%	+108.96%	4.4TCr
REVOLUTION MEDICINES, INC.	+8.53%	+0.57%	+213.45%	+793.20%	3.81TCr
CELLTRION, INC.	-1.86%	+11.46%	+26.67%	+61.40%	3.63TCr
GENMAB A/S	-2.97%	-9.84%	+88.86%	+76.17%	3.26TCr
WUXI BIOLOGICS (CAYMAN) INC.	-2.18%	+5.68%	+36.21%	-0.69%	2.55TCr
Average	+0.40%	+2.24%	+56.49%	+146.86%	4.49TCr
Weighted average by Cap.	+0.14%	+2.44%	+52.19%	+139.10%

Employees

Sector